BioLife Solutions
BLFS31.9807.35% ( +2.190 )
BioLife Solutions (BLFS)
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United State...
- Open
- 30.050
- High
- 33.140
- Low
- 30.050
- Prev. Close
- 29.790
- Volume
- 2.71M
- Turnover
- 87.92M
- Avg Price
- 32.433
- Bid/Ask Ratio
- --
- Amplitude
- 10.37%
- 52wk High
- 33.140
- Volume Ratio
- 0.71
- Turnover Ratio
- 6.35%
BioLife Solutions Analyst Rating
View MoreForecast & Rating
Jul 27, 2026Price forecast
$31.13-2.67%
Forecast & RatingHold
9analysts
- Strong buy22.22%
- Buy0.00%
- Hold77.78%
- Sell0.00%
- Strong sell0.00%
News
- Quartr · 17 hours ago
RGEN: Raised 2026 guidance after strong Q2 growth, margin gains, and BioLife acquisition announcement
- PR Newswire · 17 hours ago
Are NG, BLFS, NRIM Obtaining Fair Deals for their Shareholders?
- PUBT · 21 hours ago
Repligen Q2 GAAP EPS drops 65.38% to $0.09; revenue rises 12% to $204 million
- Global Report · 23 hours ago
Cross-Sector Divergence: How Global Shifts Fracture US and International Equities in Mid-2026
- PR Newswire · Jul 23 at 11:10 AM
Are UTZ, BLFS, FNWD Obtaining Fair Deals for their Shareholders?
- Simplywall · Jul 23 at 08:19 AM
Is Repligen (RGEN) Still Undervalued Following Its $1.5b BioLife Deal?
